Model for End-Stage Liver Disease (MELD) exception for hereditary hemorrhagic telangiectasia

Liver Transplantation

Volumn 12, Issue 12 SUPPL. 3, 2006, Pages

  Garcia Tsao, Guadalupe ^a   Gish, Robert G ^b   Punch, Jeffrey ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL RADIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; AUTOSOMAL DOMINANT DISORDER; BILE DUCT OBSTRUCTION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; HIGH OUTPUT HEART FAILURE; HUMAN; LIVER CIRCULATION; LIVER FAILURE; LIVER TRANSPLANTATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SCORING SYSTEM; STANDARDIZATION;

HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; SEVERITY OF ILLNESS INDEX; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TISSUE AND ORGAN PROCUREMENT;

EID: 33845486517     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20978     Document Type: Article

References (6)

1. Azoulay D, Precetti S, Emile JF, Ichai P, Gillon MC, Duclos-Vallee JC, et al. Liver transplantation for intrahepatic Rendu-Osler-Weber's disease: the Paul Brousse hospital experience. Gastroenterol Clin Biol 2002;26:828-834.
2. Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000;343:931-936.
3. Blewitt RW, Brown CM, Wyatt JI. The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia. Histopathology 2003;42:265-269.
4. Neumann UP, Knoop M, Langrehr JM, Keck H, Bechstein WO, Lobeck H, et al. Effective therapy for hepatic M. Osler with systemic hypercirculation by ligation of the hepatic artery and subsequent liver transplantation. Transpl Int 1998:11:323-326.
5. Odorico JS, Hakim MN, Becker YT, Van Der WW, Musat A, Knechtle SJ, et al. Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. Liver Transpl Surg 1998;4:483-490.
6. Livneh A, Langevitz P, Morag B, Catania A, Pras M. Functionally reversible hepatic arteriovenous fistulas during pregnancy in patients with hereditary hemorrhagic telangiectasia. South Med J 1988;81:1047-1049.